Consequently, several enzymes involved in LD formation or breakdown, such as ACC, fatty acid synthase (FASN), 3-hydroxy-3-methylglutaryl monoacyl-CoA reductase (HMGCR), and stearoyl-CoA desaturase (SCD), have been identified as potential therapeutic targets in cancer treatment. This evidence concerns the gene FASN and cancer.